My HPRA: Register

The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail vetinfo@hpra.ie


Heptavac P Plus



Intervet Ireland LimitedVPA10996/146/001

Main Information

Trade NameHeptavac P Plus
Active SubstancesClostridium perfringens beta toxoid (strains 554 and 578)
Clostridium perfringens epsilon toxoid (strain 603)
Clostridium septicum toxoid (strain 505)
Clostridium tetani toxoid (strain s1123/91)
Clostridium novyi toxoid (strain 754)
Clostridium chauvoei cells and equivalent toxoid of strain 655
Clostridium chauvoei cells and equivalent toxoid of strain 656
Clostridium chauvoei cells and equivalent toxoid of strain 657
Clostridium chauvoei cells and equivalent toxoid of strain 658
Clostridium chauvoei cells and equivalent toxoid of strain 1048
Formalin pasteurella haemolytica strain a1 (s1006/77)
Formalin pasteurella haemolytica strain a2 (s1126/92)
Formalin pasteurella haemolytica strain a6 (s1084/81)
Formalin pasteurella haemolytica strain a7 (s1078/81)
Formalin pasteurella haemolytica strain a9 (s994/77)
Formalin pasteurella trehalosi strain t3 (s1109/84)
Formalin pasteurella trehalosi strain t4 (s1085/81)
Formalin pasteurella trehalosi strain t10 (s1075/81)
Formalin pasteurella trehalosi strain t15 (s1105/84)
Dosage FormSuspension for injection
Licence HolderIntervet Ireland Limited
License Holder AddressMagna Drive
Magna Business Park, Citywest Road
Dublin 24
Ireland
Licence NumberVPA10996/146/001

Group Information

ATC CodeQI04AB05 clostridium + pasteurella
Therapeutic ClassImmunological - Inactivated Vaccine
SpeciesSheep

Status

License statusAuthorised
Licence Issued21/03/2003
Legal StatusLR: Licensed Retailer as defined in national legislation

Documents

Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
VariationsPDF Version

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back
Follow medicine

Print